To determine whether KAT6A regulates the sensitivity of ovarian cancer cells to platinum-based chemotherapeutics, we measured the IC50 values of cisplatin in KAT6A-silenced cells and control cells. This evidence concerns the gene KAT6A and ovarian carcinoma.